Daniel oversees the SNP array and sequence analysis pipeline in the Neale lab, with a primary focus on furthering genetic discovery in complex psychiatric disease through collaborative partnerships and high-throughput data analysis. His post-doctoral research has been focused on deciphering the role of rare genetic variation in schizophrenia. Daniel received his PhD in 2012 from the University of Colorado, Boulder (supervised by Dr. Matthew Keller and Dr. Matthew McQueen). During his time in Colorado, his research investigated the detection of autozygosity (a genetic signature of inbreeding), and its role in general cognitive ability and schizophrenia liability.